HIGH LEVELS OF ERCC1 ARE ASSOCIATED WITH CISPLATIN RESISTANCE IN NEUROBLASTOMA

被引：0
|
作者：
Meret, Henry [1 ]
Wang, Zhihong [1 ]
Liu, Yimin [1 ]
机构：
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：784 / 784
页数：1
相关论文
共 50 条
  • [21] XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells:: Role of ERCC1 in homologous recombination repair
    Cummings, Michele
    Higginbottom, Karen
    McGurk, Claire J.
    Wong, Oscar Gee-Wang
    Koberle, Beate
    Oliver, R. Timothy D.
    Masters, John R.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (02) : 166 - 175
  • [22] ERCC1 intron 1 was associated with breast cancer risk
    Mojgan, Hosseini
    Massoud, Houshmand
    Ahmad, Ebrahimi
    ARCHIVES OF MEDICAL SCIENCE, 2012, 8 (04) : 655 - 658
  • [23] The Impacts of ERCC1 Gene Exon VIII Alternative Splicing on Cisplatin-Resistance in Ovarian Cancer Cells
    Sun, Yehong
    Li, Tiyuan
    Ma, Kewei
    Tian, Zhongkai
    Zhu, Ying
    Chen, Fuqiang
    Hu, Gang
    CANCER INVESTIGATION, 2009, 27 (09) : 891 - 897
  • [24] IS CISPLATIN OTOTOXICITY RELATED WITH GENOTYPE OF DNA REPAIR GENES ERCC1, ERCC2, XRCC1?
    Turan, C.
    Kantar, M.
    Aktan, C.
    Kosova, B.
    Orman, M.
    Kose, T.
    Bilgen, C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S304 - S304
  • [25] ERCC1 and clinical resistance to platinum-based therapy
    Reed, E
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6100 - 6102
  • [26] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 702 - 710
  • [27] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Waldstrom, M.
    Steffensen, K. D.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    APMIS, 2008, 116 (03) : 239 - 240
  • [29] The mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity of cisplatin, carboplatin and gemcitabine in human lung cancer cell lines
    Horio, Yoshitsugu
    Shimizu, Jun-ichi
    Osada, Hirotaka
    Hida, Toyoaki
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Takahashi, Takashi
    Sekido, Yoshitaka
    Yatabe, Yasushi
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3570S - 3571S
  • [30] ERCC1 and response to chemotherapy
    Soria, J. -C.
    EJC SUPPLEMENTS, 2007, 5 (08): : 15 - 15
12345